Targeted therapy for cervical cancer
Targeted therapy is designed to identify and counteract unique qualities of specific cancer cells. Targeted therapy drugs work by attaching themselves to proteins or receptors on cancer cells, either killing the cells or helping other therapies, such as chemotherapy, work better. Among the drugs used in targeted therapy are so-called angiogenesis inhibitors, designed to prevent cancer cells from developing blood vessels that feed tumors.
One common targeted therapy drug used to treat cervical cancers is bevacizumab (Avastin®), a monoclonal antibody and angiogenesis inhibitor that may be used in combination with cisplatin (Platinol®), a chemotherapy treatment.